Jefferies Financial Group Inc. Sells 1,582 Shares of Axon Enterprise, Inc $AXON

Jefferies Financial Group Inc. cut its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 53.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,381 shares of the biotechnology company’s stock after selling 1,582 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Axon Enterprise were worth $784,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of AXON. Creative Financial Designs Inc. ADV bought a new position in shares of Axon Enterprise in the fourth quarter valued at about $28,000. New Millennium Group LLC bought a new position in shares of Axon Enterprise in the third quarter valued at about $29,000. Sound Income Strategies LLC raised its position in shares of Axon Enterprise by 550.0% in the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after purchasing an additional 44 shares during the period. Camelot Portfolios LLC bought a new position in shares of Axon Enterprise in the fourth quarter valued at about $30,000. Finally, Lodestone Wealth Management LLC bought a new position in shares of Axon Enterprise in the fourth quarter valued at about $35,000. 79.08% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on AXON. Needham & Company LLC dropped their price objective on shares of Axon Enterprise from $870.00 to $600.00 and set a “buy” rating on the stock in a research report on Friday, February 20th. William Blair reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 3rd. Wall Street Zen raised shares of Axon Enterprise from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. UBS Group dropped their price objective on shares of Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a research report on Thursday, May 7th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $712.75.

Axon Enterprise Trading Up 2.1%

AXON stock opened at $448.72 on Friday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27. The company’s 50-day simple moving average is $407.53 and its 200 day simple moving average is $494.65. Axon Enterprise, Inc has a 52 week low of $339.01 and a 52 week high of $885.91. The company has a market capitalization of $36.17 billion, a PE ratio of 180.21, a price-to-earnings-growth ratio of 7.99 and a beta of 1.44.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, beating the consensus estimate of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The business had revenue of $807.35 million for the quarter, compared to the consensus estimate of $778.91 million. During the same period in the prior year, the company posted $1.47 earnings per share. Axon Enterprise’s revenue was up 33.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Axon Enterprise, Inc will post 1.82 earnings per share for the current year.

Insider Buying and Selling at Axon Enterprise

In related news, CAO Jennifer H. Mak sold 1,500 shares of the company’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $573.45, for a total value of $860,175.00. Following the transaction, the chief accounting officer directly owned 12,240 shares in the company, valued at approximately $7,019,028. This represents a 10.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Jeri Williams sold 157 shares of the company’s stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $490.00, for a total transaction of $76,930.00. Following the completion of the transaction, the director owned 1,159 shares in the company, valued at $567,910. This trade represents a 11.93% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 3,855 shares of company stock valued at $1,837,408. 4.20% of the stock is currently owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.